| CIVI |
CIVITAS RESOURCES, INC. |
Clark Morris R |
Director
|
2026-01-30 |
D - D |
43,317 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Colis Peter George |
|
2026-01-30 |
C - D |
6,154,683 |
0.00 |
0.00 |
811,183 |
| LIFE |
Ethos Technologies Inc. |
Colis Peter George |
|
2026-01-30 |
C - D |
128,893 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Colis Peter George |
|
2026-01-30 |
C - D |
214,822 |
0.00 |
0.00 |
0 |
| LIFE |
Ethos Technologies Inc. |
Colis Peter George |
|
2026-01-30 |
C - A |
6,154,683 |
0.00 |
0.00 |
6,154,683 |
| LIFE |
Ethos Technologies Inc. |
Colis Peter George |
|
2026-01-30 |
C - A |
128,893 |
0.00 |
0.00 |
128,893 |
| LIFE |
Ethos Technologies Inc. |
Colis Peter George |
|
2026-01-30 |
C - A |
214,822 |
0.00 |
0.00 |
214,822 |
| CTNM |
Contineum Therapeutics, Inc. |
Watkins Tim |
Officer
|
2026-01-30 |
A - A |
160,000 |
0.00 |
0.00 |
160,000 |
| CTNM |
Contineum Therapeutics, Inc. |
Lorrain Daniel S. |
Officer
|
2026-01-30 |
A - A |
160,000 |
0.00 |
0.00 |
160,000 |
| CTNM |
Contineum Therapeutics, Inc. |
Lorrain Daniel S. |
Officer
|
2026-01-30 |
A - A |
6,500 |
0.00 |
0.00 |
6,500 |
| CTNM |
Contineum Therapeutics, Inc. |
Stengone Carmine N. |
Director
Officer
|
2026-01-30 |
A - A |
445,000 |
0.00 |
0.00 |
445,000 |
| CTNM |
Contineum Therapeutics, Inc. |
Slover Peter T |
Officer
|
2026-01-30 |
A - A |
192,000 |
0.00 |
0.00 |
192,000 |
| CTNM |
Contineum Therapeutics, Inc. |
Healy John Stephen |
Officer
|
2026-01-30 |
A - A |
206,411 |
0.00 |
0.00 |
206,411 |
| CIVI |
CIVITAS RESOURCES, INC. |
Counts Travis L |
Officer
|
2026-01-30 |
D - D |
61,568 |
0.00 |
0.00 |
0 |
| CIVI |
CIVITAS RESOURCES, INC. |
Counts Travis L |
Officer
|
2026-01-30 |
D - D |
82,730 |
0.00 |
0.00 |
0 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
York Charles N II |
|
2026-01-30 |
A - A |
188,000 |
0.00 |
0.00 |
188,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
York Charles N II |
|
2026-01-30 |
A - A |
126,000 |
0.00 |
0.00 |
126,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
VASCONCELLES MICHAEL |
|
2026-01-30 |
A - A |
171,000 |
0.00 |
0.00 |
171,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
VASCONCELLES MICHAEL |
|
2026-01-30 |
A - A |
114,000 |
0.00 |
0.00 |
114,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
Dubow Adam |
|
2026-01-30 |
A - A |
105,000 |
0.00 |
0.00 |
105,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
Dubow Adam |
|
2026-01-30 |
A - A |
70,000 |
0.00 |
0.00 |
70,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
Merendino Lauren |
|
2026-01-30 |
A - A |
110,000 |
0.00 |
0.00 |
110,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
Merendino Lauren |
|
2026-01-30 |
A - A |
74,000 |
0.00 |
0.00 |
74,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
Bender Jeremy |
|
2026-01-30 |
A - A |
355,000 |
0.00 |
0.00 |
355,000 |
| DAWN |
Day One Biopharmaceuticals, Inc. |
Bender Jeremy |
|
2026-01-30 |
A - A |
237,000 |
0.00 |
0.00 |
237,000 |